sorafenib has been researched along with demecolcine in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (demecolcine) | Trials (demecolcine) | Recent Studies (post-2010) (demecolcine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,207 | 4 | 66 |
| Protein | Taxonomy | sorafenib (IC50) | demecolcine (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8345 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, P; Shaikh, N; Sharma, M | 1 |
1 other study(ies) available for sorafenib and demecolcine
| Article | Year |
|---|---|
An improved approach for predicting drug-target interaction: proteochemometrics to molecular docking.
Topics: Aldehyde Reductase; Anthracyclines; Antineoplastic Agents; Colchicine; Databases, Protein; Demecolcine; Drug Interactions; Models, Biological; Molecular Docking Simulation; Niacinamide; Phenylurea Compounds; Proteomics; Reproducibility of Results; Sorafenib; Support Vector Machine | 2016 |